Search Results 501-510 of 18267 for Hepatitis b

1. Canakinumab (subcutaneous route) - Side effects & uses - Mayo Clinic

   Hepatitis B, history of or; Hepatitis C, history of or; Immune system problem (eg, HIV or AIDS) or; Infection, active or history of or; Tuberculosis, active ...

2. A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Effectiveness of AMG 397 in Subjects With Multiple Myeloma, NHL, and AML - Mayo Clinic

   ... hepatitis B core antibody: hepatitis B virus DNA by polymerase chain reaction (PCR) is necessary. Detectable hepatitis B virus DNA suggests occult hepatitis B.

3. Hemochromatosis - Doctors and departments - Mayo Clinic

   problems, Esophageal varices, Hepatitis C, Primary sclerosing cholangitis, Hepatitis B, Cholangiocarcinoma, Portal hypertension, Hemochromatosis, Alcoholic ...

4. Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma - Mayo Clinic

   Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma ... hepatitis B core ...

5. Alcoholic Hepatitis: A Multicenter, Observational Study by the TREAT Consortium - Mayo Clinic

   About this study. To conduct a prospective, multicenter, observational study of patients with well-characterized alcoholic hepatitis (AH) and frequency ...

6. Group B strep disease - Diagnosis & treatment - Mayo Clinic

   If your newborn might have group B strep disease, a sample of your baby's blood or spinal fluid likely will be taken. A lab checks the sample for the ...

7. Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139) - Mayo Clinic

   Known central nervous system (CNS) lymphoma · History of interstitial lung disease, prior malignancy, active autoimmune disease, positive test for hepatitis B or ...

8. Study Treating Patients with Relapsed or Refractory Aggressive B-cell Lymphomas Using Nivolumab with or without Varlilumab - Mayo Clinic

   Patients with evidence of hepatitis B virus (HBV) are eligible provided there is minimal hepatic injury and the patient has undetectable HBV on suppressive ...

9. Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma - Mayo Clinic

   ... B-cell non-Hodgkin lymphoma that has returned (recurrent) or did not respond ... hepatitis B and C are eligible at the discretion of the treating ...

10. A Study to Compare the Effectiveness and Safety of ABT-493/ABT-530 to Sofosbuvir Given Together with Declatasvir in Adults with a Chronic Hepatitis C Virus Infection - Mayo Clinic

    Positive test result at screening for hepatitis B surface antigen (HBsAg) or anti-human immunodeficiency virus antibody (HIV Ab). HCV genotype performed ...